Evidence map›Paper›PMID 41582414›Full record

ArticleBritish journal of haematology2026

Immune-related toxicity profile after haematopoietic stem cell transplantation in patients with B-ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab.

Olayinka Okeleji, David McCall, Branko Cuglievan, Amber Gibson, Demetrios Petropoulos, Priti Tewari, Jeremy Connors, Irtiza N Sheikh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Olayinka OkelejiDepartment of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
David McCallDepartment of Pediatrics, Leukemia Section, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Branko CuglievanDepartment of Pediatrics, Leukemia Section, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Amber GibsonDepartment of Pediatrics, Leukemia Section, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-9146-4702
Demetrios PetropoulosDepartment of Pediatrics, Stem Cell Transplantation and Cellular Therapy Section, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Priti TewariDepartment of Pediatrics, Stem Cell Transplantation and Cellular Therapy Section, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-4819-5276
Jeremy ConnorsDepartment of Pediatrics, Stem Cell Transplantation and Cellular Therapy Section, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Irtiza N SheikhDepartment of Pediatrics, Stem Cell Transplantation and Cellular Therapy Section, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allogeneic stem cell transplantB‐ALLimmune reconstitutioninfectionremissionviral reactivation

Identifiers

PMID41582414
PMCPMC13071464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.